Harrow, Inc.
HROW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001360214
In the last 90 days, Harrow, Inc. insiders filed 0 open-market purchases and 1 sale; 223 institutions reported holding it in 13F filings for Q2 2026, worth $912.6M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Harrow, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 88 | 81 | −7 |
| Shares | 16.2M | 15.3M | −887.0K (−5.5%) |
| Value | $136.6M | $184.5M | +$48.0M (+35.1%) |
New holders (6)
Institutions that held Harrow, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EAM Investors, LLC | 224,046 | $2.70M | 0.59% |
| EAM Global Investors LLC | 66,420 | $802.0K | 0.21% |
| Corsair Capital Management, L.P. | 27,790 | $335.0K | 0.15% |
| Schonfeld Strategic Advisors LLC | 11,500 | $139.0K | 0.00% |
| Occudo Quantitative Strategies LP | 10,447 | $126.0K | 0.01% |
| China Universal Asset Management Co., Ltd. | 253 | $3.00K | 0.00% |
Sold out (13)
Institutions that held Harrow, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Stansberry Asset Management, LLC | 141,040 | $1.03M |
| Assenagon Asset Management S.A. | 133,415 | $971.0K |
| Boothbay Fund Management, LLC | 108,929 | $793.0K |
| Jacobs Levy Equity Management, Inc | 43,545 | $317.0K |
| First Trust Advisors LP | 36,301 | $264.0K |
| Citadel Advisors LLC | 24,413 | $178.0K |
| Bailard, Inc. | 16,837 | $123.0K |
| Bank of Montreal | 10,750 | $79.0K |
| Leeward Financial Partners, LLC | 10,000 | $73.0K |
| Clarus Group, Inc. | 10,000 | $73.0K |
| Captrust Financial Advisors | 7,000 | $51.0K |
| Johnson Financial Group, Inc. | 6,329 | $46.0K |
| Group One Trading, L.P. | 619 | $5.00K |